Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takanori Ueda

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 1, 2004
[Recent progress in diagnosis of and therapy for patients with leukemia]Takanori Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Chemotherapy]Takanori Ueda
International Journal of Clinical Oncology|October 12, 2007
Update on molecular-targeted therapy in hematologic malignanciesTakanori Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 13, 2003
[Mode of existence and dynamics of uric acid in blood]Takanori Ueda
International Journal of Clinical Oncology|December 21, 2013
Current status of molecular targeted therapy for hematologic malignancies: introductionTakanori Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 13, 2003
[Secondary hypouricemia in patients with malignant disease]Shin Imamura, Takanori Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 16, 2008
[Primary hyperuricemia due to decreased renal uric acid excretion]Takahiro Yamauchi, Takanori Ueda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[Nilotinib as a second-line treatment for chronic myeloid leukemia]Takahiro Yamauchi, Takanori Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2014
[Chemotherapy]Shinji Kishi, Takanori Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Imatinib therapy for patients with chronic myelogenous leukemia]Yasukazu Kawai, Takanori Ueda
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 1, 2004
[Recent progress in diagnosis of and therapy for patients with leukemia]Takanori Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Chemotherapy]Takanori Ueda
International Journal of Clinical Oncology|October 12, 2007
Update on molecular-targeted therapy in hematologic malignanciesTakanori Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 13, 2003
[Mode of existence and dynamics of uric acid in blood]Takanori Ueda
International Journal of Clinical Oncology|December 21, 2013
Current status of molecular targeted therapy for hematologic malignancies: introductionTakanori Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 13, 2003
[Secondary hypouricemia in patients with malignant disease]Shin Imamura, Takanori Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 16, 2008
[Primary hyperuricemia due to decreased renal uric acid excretion]Takahiro Yamauchi, Takanori Ueda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2011
[Nilotinib as a second-line treatment for chronic myeloid leukemia]Takahiro Yamauchi, Takanori Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2014
[Chemotherapy]Shinji Kishi, Takanori Ueda
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Imatinib therapy for patients with chronic myelogenous leukemia]Yasukazu Kawai, Takanori Ueda
Pageof 21